Protect local news!

Be one of 5,000 supporters to make a monthly gift during our fall member drive and help strengthen our nonprofit newsroom.
Logged in as
Audience-funded nonprofit news
radio tower icon laist logo
Next Up:
0:00
0:00
Subscribe
  • Listen Now Playing Listen

This archival content was originally written for and published on KPCC.org. Keep in mind that links and images may no longer work — and references may be outdated.

KPCC Archive

Popular new approach to slow the spread of HIV may generate a more resistant virus: USC study

SAN ANSELMO, CA - NOVEMBER 23:  Bottles of antiretroviral drug Truvada are displayed at Jack's Pharmacy on November 23, 2010 in San Anselmo, California. A study published by the New England Journal of Medicine showed that men who took the daily antiretroviral pill Truvada significantly reduced their risk of contracting HIV. (Photo Illustration by Justin Sullivan/Getty Images)
The antiretroviral drug Truvada. A USC study says aggressive early treatment of HIV could create drug-resistant strains of the virus.
(
Justin Sullivan/Getty Images
)

One year ago, Congress defunded public media. Now that we're 100% community funded, please become a sustaining member or increase your existing membership today.

Listen 1:00
Popular new approach to slow the spread of HIV may generate a more resistant virus: USC study

In recent months, public health officials around the country have started using a popular new method to prevent the spread of HIV called "test and treat." But a USC study advises that this approach could be counter productive. 

The new strategy calls for universal HIV testing of sexually active adolescents and adults as part of routine health screenings, followed by immediate drug therapy for all who test positive for the virus – instead of waiting until their immune system is more compromised. 

Public health officials nationwide have embraced the strategy, as it’s been shown to substantially reduce the number of HIV cases and resulting deaths from AIDS. Some experts suggest “test and treat” could even eradicate HIV.

But USC researchers from the Schaeffer Center for Health Policy and Economics say their mathematical models indicate the need for caution. 

The models predicted that if the "test and treat" strategy were applied for ten years, the prevalence of multi-drug resistant HIV strains would nearly double, from 4.79 percent to 9.1 percent, says Neeraj Sood, an associate professor at the Schaeffer Center.

“That is a worry because if you have multi-drug resistant HIV, then treatment for HIV is less effective for you,”  Sood says, adding that the uncertainty of how new strains may evolve and whether new drugs can be developed to battle them remains unknown.

Sood advises a more cautious approach, in which public health officials would continue with aggressive HIV testing, but postpone early-stage treatment of the virus.

Sponsored message

The study showed this more modest strategy offers an almost 18 percent reduction of HIV infections, without the increase in drug-resistant HIV strains.

“So you’re getting half the short term benefits,” he says, “but you’re hedging your long term bets.”

The USC researchers said their study also calls into question the claim that "test and treat" could eradicate HIV. 

Under a best case scenario, “test and treat” would generate about a 34 percent reduction in new infections and a 19 percent drop in the number of deaths over ten years, says Sood. “Sizeable benefits, but not close to eradicating the disease."

Sood says he and his team of researchers based their assessment on mathematical models that focused on LA County’s population of sexually active gay men,  which accounts for 82 percent of all county residents infected with HIV/AIDS.

Clin Infect Dis. 2013 Sood Cid_cit158[1]

One year ago, Congress voted to defund public media, eliminating a critical $1.7 million from our budget every year going forward. But they couldn’t silence us, and we’re not going anywhere. LAist is now 100% community funded and that means we’re taking our future into our own hands and turning to you to keep local reporting strong.

You come to LAist because you want independent reporting and trustworthy local information. Our nonprofit newsroom doesn’t answer to shareholders looking to turn a profit. Instead, we answer to you and our communities. We are free to follow facts wherever they lead and to hold power to account without fear or favor. Our only loyalty is to our readers and listeners and our mission: to inform, engage, and strengthen Southern California’s communities.

If this story helped you, please become a monthly member today to help sustain this mission. It just takes 1 minute to donate below.
Senior Vice President News, Editor in Chief

Make your tax-deductible donation today